BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12213260)

  • 1. Identification of threonine 422 in transmembrane domain alpha M4 of the nicotinic acetylcholine receptor as a possible site of interaction with hydrocortisone.
    Garbus I; Roccamo AM; Barrantes FJ
    Neuropharmacology; 2002 Jul; 43(1):65-73. PubMed ID: 12213260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration in ion channel function of mouse nicotinic acetylcholine receptor by mutations in the M4 transmembrane domain.
    Tamamizu S; Lee Y; Hung B; McNamee MG; Lasalde-Dominicci JA
    J Membr Biol; 1999 Jul; 170(2):157-64. PubMed ID: 10430659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of periodic tryptophan substitutions in the alpha M4 transmembrane domain of the Torpedo californica nicotinic acetylcholine receptor.
    Tamamizu S; Guzmán GR; Santiago J; Rojas LV; McNamee MG; Lasalde-Dominicci JA
    Biochemistry; 2000 Apr; 39(16):4666-73. PubMed ID: 10769122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic receptor fourth transmembrane domain: hydrogen bonding by conserved threonine contributes to channel gating kinetics.
    Bouzat C; Barrantes F; Sine S
    J Gen Physiol; 2000 May; 115(5):663-72. PubMed ID: 10779322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan substitutions at the lipid-exposed transmembrane segment M4 of Torpedo californica acetylcholine receptor govern channel gating.
    Lasalde JA; Tamamizu S; Butler DH; Vibat CR; Hung B; McNamee MG
    Biochemistry; 1996 Nov; 35(45):14139-48. PubMed ID: 8916899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic contributions of residues in the M1 transmembrane domain of the nicotinic receptor to channel gating.
    Spitzmaul G; Corradi J; Bouzat C
    Mol Membr Biol; 2004; 21(1):39-50. PubMed ID: 14668137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid matters: nicotinic acetylcholine receptor-lipid interactions (Review).
    Barrantes FJ
    Mol Membr Biol; 2002; 19(4):277-84. PubMed ID: 12512774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural dynamics of the M4 transmembrane segment during acetylcholine receptor gating.
    Mitra A; Bailey TD; Auerbach AL
    Structure; 2004 Oct; 12(10):1909-18. PubMed ID: 15458639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subunit-specific contribution to agonist binding and channel gating revealed by inherited mutation in muscle acetylcholine receptor M3-M4 linker.
    Shen XM; Ohno K; Sine SM; Engel AG
    Brain; 2005 Feb; 128(Pt 2):345-55. PubMed ID: 15615813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subunit-selective contribution to channel gating of the M4 domain of the nicotinic receptor.
    Bouzat C; Gumilar F; del Carmen Esandi M; Sine SM
    Biophys J; 2002 Apr; 82(4):1920-9. PubMed ID: 11916850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of muscle nicotinic acetylcholine receptors by the glucocorticoid hydrocortisone. Possible allosteric mechanism of channel blockade.
    Bouzat C; Barrantes FJ
    J Biol Chem; 1996 Oct; 271(42):25835-41. PubMed ID: 8824214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP; Xie Y; Dangott LJ; Cohen JB
    Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone inhibition of wild-type and αD200Q nicotinic acetylcholine receptors.
    Dworakowska B; Nurowska E; Dołowy K
    Chem Biol Drug Des; 2018 Sep; 92(3):1610-1617. PubMed ID: 29729083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of the non-alpha subunit residues (loop D) to agonist binding and channel gating in the muscle nicotinic acetylcholine receptor.
    Akk G
    J Physiol; 2002 Nov; 544(3):695-705. PubMed ID: 12411516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrocortisone and 11-desoxycortisone modify acetylcholine receptor channel gating.
    Bouzat C; Barrantes FJ
    Neuroreport; 1993 Feb; 4(2):143-6. PubMed ID: 8453051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of valine 7' of TMD2 to gating of neuronal alpha3 receptor subtypes.
    Nieves-Cintrón M; Caballero-Rivera D; Navedo MF; Lasalde-Dominicci JA
    J Neurosci Res; 2006 Dec; 84(8):1778-88. PubMed ID: 17044037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A re-examination of adult mouse nicotinic acetylcholine receptor channel activation kinetics.
    Salamone FN; Zhou M; Auerbach A
    J Physiol; 1999 Apr; 516 ( Pt 2)(Pt 2):315-30. PubMed ID: 10087333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan substitutions at lipid-exposed positions of the gamma M3 transmembrane domain increase the macroscopic ionic current response of the Torpedo californica nicotinic acetylcholine receptor.
    Cruz-Martín A; Mercado JL; Rojas LV; McNamee MG; Lasalde-Dominicci JA
    J Membr Biol; 2001 Sep; 183(1):61-70. PubMed ID: 11547353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroids differentially inhibit the nicotinic acetylcholine receptor.
    Garbus I; Bouzat C; Barrantes FJ
    Neuroreport; 2001 Feb; 12(2):227-31. PubMed ID: 11209925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.